TOKYO, Sept 24 (Reuters) - Japan’s third-largest drugmaker Daiichi Sankyo Co said on Wednesday its open offer to buy up to 20 percent of India’s generic drugmaker Ranbaxy Laboratories Ltd was oversubscribed.
TOKYO, Sept 24 (Reuters) - Japan’s third-largest drugmaker Daiichi Sankyo Co said on Wednesday its open offer to buy up to 20 percent of India’s generic drugmaker Ranbaxy Laboratories Ltd was oversubscribed.
